ArsenalBio is a programmable cell therapy company that uses synthetic biology to engineer T cells with multiple integrated genetic circuits. Their platform writes large synthetic DNA programs into immune cells, enabling logic-gated, multi-antigen targeting for solid tumors — a major unmet need in oncology that conventional CAR-T cannot address.